Top Core and Group Health Stories
Ozempic's price has fallen 33% since 2021: HHS
By Allison BellThe price of Wegovy, the diabetes control drug's glamorous anti-obesity sibling, may also be falling, according to a Health and Human Services report.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
The price of Wegovy, the diabetes control drug's glamorous anti-obesity sibling, may also be falling, according to a Health and Human Services report.